This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
Home
Products
Admelog® (insulin lispro 100 units/ml (GB ONLY))
Admelog Hero

ADMELOG®

insulin lispro 100 units/ml (GB ONLY)

This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

The first rapid acting insulin biosimilar of Humalog* approved in the UK and EU1

admelog pen banner

Profile

25% lower NHS list price vs Humalog cartridges and pre-filled pens and 15% lower NHS list price vs Humalog vials2

1:1 initial unit dosing* – available in the SoloSTAR® pen, cartridges and vials1

*Changes in strength, brand, type, species and/or method of manufacture may result in the need for a change in dosage. Transferring to a different insulin should be done under strict medical supervision.

Similar PK/PD profile (T1DM)3, efficacy, safety and tolerability profiles (T1DM and T2DM)4-5

1/3

25% lower NHS list price vs Humalog cartridges and pre-filled pens and 15% lower NHS list price vs Humalog vials2

1:1 initial unit dosing* – available in the SoloSTAR® pen, cartridges and vials1

*Changes in strength, brand, type, species and/or method of manufacture may result in the need for a change in dosage. Transferring to a different insulin should be done under strict medical supervision.

Similar PK/PD profile (T1DM)3, efficacy, safety and tolerability profiles (T1DM and T2DM)4-5

References

Abbreviations:

DSN, diabetes specialist nurse; EU, European Union, NHS, National Health Service; PD, pharmacodynamic; PK, pharmacokinetic; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; UK, United Kingdom.

 

References:

  1. Admelog SmPC October 2021

  2. The NHS Dictionary of Medicines and Devices Admelog: solution for injection. Available at: https://services.nhsbsa.nhs.uk/dmd-browser/search/results?ampName=admelog&searchType=AMP&showInvalidItems=false&size=50 Last accessed: October 2023

  3. Kapitza C, et al. Diabetes Obes Metab. 2017;19(5):622–7.

  4. Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26

  5. Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.

  6. Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26

  7. Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.



     

READ MORE EVIDENCE

Diabetes Stories

Watch peer-to-peer videos of payors and healthcare professionals sharing best practices of adopting a rapid acting insulin biosimilar.
Some of these videos are related to HCPs sharing their experiences with a different rapid acting insulin biosimilar.

Paula Johnston - Lead Inpatient Diabetes Specialist Nurse

Length: 02:22

In this video you can learn from Paula Johnston how she achieved a positive patient experience with this biosimilar and how she carried out an opportunistic switch of existing patients, when appropriate.

Dr Saqib Mahmud - Primary Care Consultant

Length: 02:55

In this video you can learn from Dr. Saqib Mahmud why he decided to prescribe a rapid acting insulin biosimilar and get practical recommendations when switching patients to a rapid acting insulin biosimilar.

Dr Duncan Browne - Consultant Endocrinologist

Length: 03:32

In this video you can learn why Duncan Browne decided to prescribe a rapid acting insulin biosimilar, how he aligned internally the local service to drive the adoption of this biosimilar in his local region and find out how the patient experience has been with this biosimilar.

Amanda Veall - Diabetes Specialist Nurse

Length: 04:16

In this video you can learn why Amanda Veall decided to prescribe a rapid acting insulin biosimilar, how she collaborated with clinical teams to drive the adoption of this biosimilar in her local region and find out how the patient experience has been with this biosimilar.

Marcus Jones - Formulary Pharmacist

Length: 03:43

In this video you can learn how Marcus Jones accelerated the adoption of a rapid acting biosimilar insulin in his local region and how he collaborated with clinical teams to make a positive start and switch.

MORE EVIDENCE

Start and Switch

Watch and download resources to support your rapid acting insulin adoption.

What is a biosimilar medicine?

Length: 07:00

Some healthcare professionals require an extra reassurance on biosimilars. Learn from Grace Vanterpool explain what a biosimilar insulin is, how it works and performs and why should the NHS use biosimilar insulin, to support you in making a positive adoption with Admelog.

Admelog Leaflet

An overview of the clinical evidence, price comparison of Admelog® versus Humalog® and information on dosing and the different presentations available.

Formulary FAQ

Factual and technical information about Admelog to support you with relevant documentation for local formulary applications.

Admelog Poster

Pharmacists and other Healthcare Professionals can print this poster and put it in drug fridges to provide information about Admelog®.

Diabetes Stories

Length: 04:02

Starting or switching to a rapid acting insulin biosimilar can raise some concerns from healthcare professionals and patients. Watch how a payor, an endocrinologist and a diabetes specialist nurse implemented a rapid acting biosimilar insulin in their local region and how they collaborated with clinical teams and patients to make a positive start and switch

Get in touch with the Diabetes Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023

MAT-XU-2302443 (v3.0) Date of Preparation: October 2023